The Bordetella pertussis Type III Secretion System Tip Complex Protein Bsp22 Is Not a Protective Antigen and Fails To Elicit Serum Antibody Responses during Infection of Humans and Mice

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

(2012) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Pertussis control: time for something new?

(2012) Thomas A. Clark et al.   TRENDS IN MICROBIOLOGY

Pertussis vaccines: where to now?

(2011) Jan T Poolman et al.   Expert Review of Vaccines

Laboratory Adaptation of Bordetella pertussis Is Associated with the Loss of Type Three Secretion System Functionality

(2011) M. E. Gaillard et al.   INFECTION AND IMMUNITY

Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis

(2011) Hyun-Ja Han et al.   PLoS One

The Present and Future Control of Pertussis

(2010) James D. Cherry   CLINICAL INFECTIOUS DISEASES

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

(2010) N. Guiso et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

The epidemiology of pertussis in Germany: past and present

(2009) Wiebke Hellenbrand et al.   BMC INFECTIOUS DISEASES

Virulence factor secretion and translocation by Bordetella species

(2009) Ruchi Shrivastava et al.   CURRENT OPINION IN MICROBIOLOGY

Bordetella pertussis Expresses a Functional Type III Secretion System That Subverts Protective Innate and Adaptive Immune Responses

(2008) N. K. Fennelly et al.   INFECTION AND IMMUNITY

BordetellaBsp22 forms a filamentous type III secretion system tip complex and is immunoprotectivein vitroandin vivo

(2008) Bob Medhekar et al.   MOLECULAR MICROBIOLOGY